Medically supervised taper for ultra high-dose opioids with significant comorbidities using a multidisciplinary approach: A case report.

The patient was discharged with an MEDD of 392 mg with additional taper as an outpatient to an MEDD of 200 mg. Adequate pain relief and resolution of side effects were achieved without the patient reporting significant withdrawal symptomatology in the outpatient setting.